5325232022-04-012022-06-305325232022-06-305325232022-04-012022-06-30in-bse-fin:OtherExpenses1Member5325232022-04-012022-06-30in-bse-fin:OtherExpenses2Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments1Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments2Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments3Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments4Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments1Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments2Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments3Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments4Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments1Member5325232022-06-30in-bse-fin:ReportableSegments1Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments2Member5325232022-06-30in-bse-fin:ReportableSegments2Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments3Member5325232022-06-30in-bse-fin:ReportableSegments3Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments4Member5325232022-06-30in-bse-fin:ReportableSegments4Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments1Member5325232022-06-30in-bse-fin:ReportableSegments1Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments2Member5325232022-06-30in-bse-fin:ReportableSegments2Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments3Member5325232022-06-30in-bse-fin:ReportableSegments3Member5325232022-04-012022-06-30in-bse-fin:ReportableSegments4Member5325232022-06-30in-bse-fin:ReportableSegments4Member5325232022-04-012022-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15325232022-04-012022-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532523BIOCONNOTLISTEDINE376G01013BIOCON LIMITEDEquity2022-04-012023-03-312022-07-272022-07-01INRMillionsFirst quarterMulti segment2022-07-2716:30:002022-07-2718:45:00Not applicable2022-04-012022-06-30UnauditedConsolidated21395000000779000000221740000007450000000165000000-58700000051260000001990000002175000000524700000019775000000239900000002399000000295000000029500000002104000000000-4300000001674000000-651000000102300000014440000002300000001074000000-51000000600300000051.211.21001.211.21Other7062000000Less: Recovery of cost from co-development partners (net)-1815000000Generics5797000000Biosimilars9766000000Novel Biologics0Research services64450000002200800000061300000021395000000Generics634000000Biosimilars708000000Novel Biologics-263000000Research services92900000020080000000390000001969000000Generics55116000000Biosimilars103150000000Novel Biologics2244000000Research services54008000000214518000000-3903000000210615000000Generics15485000000Biosimilars81455000000Novel Biologics1475000000Research services21192000000119607000000-4473000000115134000000Items that will not be reclassified to profit or loss-194000000-194000000-28000000Items that will be reclassified to profit or loss-856000000-856000000-371000000